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In an earlier study we showed that tretinoin could prevent 
corticosteroid-induced skin atrophy in hairless mice. In this 
study, we examined the histochemical, biochemical, and im-
rnunochemical changes that accompanied the atrophy and its 
prevention. Mice were treated dorsally for 3 weeks in 
the morning and afternoon (AM: PM) as follows: 1) vehi-
cle: vehicle, 2) steroid: vehicle, 3) steroid: tretinoin. Tretin-
oin concentration was 0.05% in an ethanol: propylene glycol 
vehicle. The steroid was clobetasol propionate (0.05%). The 
normally sparse dermal glycosaminoglycans were further re-
duced by steroid: vehicle treatment and increased to greater 
than vehicle: vehicle amounts by steroid: retinoid. Mast cells 
T he hairless mouse has been shown to be a relevant and rapid model in which to examine the consequences of prolonged application of topical corticosteroids [1,2]. As opposed to the months required in clinical use to produce skin atrophy in humans, within 2-3 weeks, 
hairless mouse skin becomes thin and transparent, clearly revealing 
the cutaneous vasculature (L.H. Kligman, unpublished results). The 
epidermis is reduced to two compressed cell layers, and the dermis is 
thinned and fragile, with the atrophy affecting even the subcutane-
ous muscle layer [1,2] . We have used this model to show thattretin-
oin (all-trans-retinoic acid), applied in the afternoon following 
morning treatment with corticosteroids, prevented these changes 
[1]. Moreover, this was accomplishe~ without interfering with the 
anti-inflammatory effect of the sterOlds. 
Early work on the in vivo effects on dermal matrix proteins of 
combined treatment with steroids and retinoids appeared, mainly, 
about two decades ago. These studies examined the corticosteroid 
suppression of wou~d healing an~ its prevention by vitamin A using 
an implanted polyvmyl sponge-mduced granuloma model [3 - 7]. 
Invariably, steroids alone reduced collagen deposition within the 
sponge but concomitant vitamin A increased it. The tensile strength 
of the wounds was enhanced by the vitamin A [3,5]. 
The few recent studies on the combined effects of retinoids and 
steroids on matrix proteins are from in vitro work. Oikarinen et at [8] 
examined collagen synthesis, mRNA levels for types I and III colla-
gens, and fibronectin mRNA in human skin fibroblast cultures. 
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were similarly affected. Biochemical quantification of gly-
cosaminoglycans confirmed the histochemical findings. 
Collagen, non-collagenous protein, and total protein content 
were reduced by the steroid. The latter two were returned to 
more normal levels by tretinoin whereas with collagen there 
was only a trend toward normal levels. Fibronectin, which 
was increased by the steroid: vehicle treatment, was reduced 
to more normal levels by steroid: tretinoin. We conclude 
that tretinoin has the ability to prevent the major steroid-in-
duced biomechanical changes in hairless mouse dermal con-
nective tissue that contribute to atrophy. Key words: mast cells/ 
dermis/matrix proteins. ] Invest Dermato11 02:241-246, 1994 
Although dexamethasone alone reduced collagen and collagen 
mRNA levels, neither 13-cis-retinoic acid (isotretinoin) nor etre-
tinate affected the reduction. The steroid did not reduce fibronectin 
mRNA whereas the retinoids alone and the retinoid-steroid treat-
ment did so [8]. 
Confirming the well-known steroid-induced inhibition of colla-
gen biosynthesis in vitro [9-13] and in vivo [10,14,15], Perez et aT 
[16] reported that dexamethasone decreased type I procollagen in 
embryonic mouse fibroblasts by decreasing the synthesis of type I 
pro collagen mRNA via a reduction in the activity of the type I 
procollagen DNA promoter region. In contrast to the effects of 
13-cis-retinoic acid on collagen metabolism in culture, tretinoin, 
the all-trans isomer, increased the activity of the promoter region. 
With the exception of the Oikarinen et at assessment of fibronec-
tin mRNA levels [8], there are no publications describing steroid-
retinoid effects on glycosaminoglycans and fibronectin. 
It is therefore in an area of sparse information that we wished to 
further characterize our earlier findings on the prevention of steroid 
atrophy in the hairless mouse model. With histochemistry we as-
sessed the steroid and tretinoin effects on glycosamilloglycalls. 
With biochemical and immunochemical techniques we examined 
the prevention by tretinoin of steroid-induced changes in collagen, 
glycosaminoglycans, and fibronectin. 
MATERIALS AND METHODS 
Treatment Groups Three groups of 20 albino Skh-hairless-l mice 
(Charles River Laboratories, Wilmington, MA), age 6-8 weeks, were 
treated topically twice daily, 5 d a week for 3 weeks on a lOAM: 4 PM 
schedule as follows: 1) vehicle : vehicle (ethanol/ propylene glycol 70 : 30 
v jv); 2) steroid (clobetasol propionate 0.05%) : vehicle; 3) steroid (clobetasol 
propionate 0.05%): tretinoin (0.05%). Applications were 100,tt1 to the dor-
sal trunk. Six untreated mice were used to monitor normal histochemistry. 
0022-202Xj94jS07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. 
241 
242 SCHW ARTZ ET AL 
A 
c 
We have found previously that the vehicle used has no effect on normal 
hairless mouse skin biology [1,17). 
Biopsies All mice were sacrificed and biopsied on the day after the final 
treatment. Dorsal trunk skin (-2 X 2 cm) was frozen at-70°C forquantifi-
cation of glycosaminoglycans, fibronectin, and collagen. Adjacent biopsies 
(1/2 X 2 cm) were processed for light microscopy and stained with Mowry's 
colloidal iron for glycosaminoglycans [18) and toluidine blue for mast cells 
(Wallace H. Clark, personal communication). Histochemistry was assessed 
on all 66 mice. All analyses were performed in a coded manner. 
Mast Cell Counts Mast cells were counted by image analysis across 1 cm 
of skin on eight randomly chosen toluidine blue-stained specimens per treat-
ment group, which were subsequently coded. The instrument was a Micro-
comp True Color System (Southern Micro Instruments, Atlanta, GA) utiliz-
ing a planar morphology package. Slides were viewed through an Olympus 
BH-2 microscope connected to a Sony-Trinitron monitor. Statistical analy-
sis was with a paired t test. 
Glycosaminoglycan Analysis Weighed skins were minced, defatted in 
acetone: ether (1: I), dried, and suspended in 10 rnl of a 0.1 M phosphate 
buffer (PH 6.5) with 0.005 M ethylenediamine tetraacetic acid (EDTA) and 
0.005 M cysteine HC!. Digestion was with papain (50 rnI containing 24 
IU/ml; Sigma Chemical Co., St. Louis, MO) for 24 h at 65°C. The digest 
was diluted to 40 ml with water and centrifuged for 2 h at 12,000 rpm 
(O - 4°C). A 1% suspension of cetylpyridinium chloride (CPC) was added 
dropwise to the supernatant [19). After storage overnight at 4 'C, the sus-
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Figure 1. Hairless mouse skin stained with Mowry'S colloidal iron to iden-
tify glycosaminoglycans (bars, 30 11m). A) Vehicle : vehicle. Occasional tiny 
foci of blue-staining material (asterisk) provide the only evidence for dennal 
GAGs in normal or vehicle-treated mice. The discrete blue structures 
(arrows) are mast cells. B) Steroid: vehicle. The only blue-staining features 
amidst the collagen are mast cells (arrows) . C) Steroid : tretinoin. Foci of blue 
staining GAGs were larger and more numerous (asterisk) . The normally 
red-staining collagen had a blUish tone. Green staining intercellular epider-
mal GAGs were abundant (arrowheads) as were mast cells (arrows) . 
pension was centrifuged at 12,000 rpm for 1 hat 0_4°C. The precipitate 
was dissolved in 300 III of n-propanol and 75 III of 1 % CPC. The glycosatni_ 
noglycans were further precipitated with 5 ml of absolute ethanol and a few 
drops of saturated sodium acetate. The precipitate was washed with ethanol 
and diethyl ether, air dried, redissolved in 1 rnI of water, transferred to 
preweighed tubes, and dried, after which the glycosaminoglycan weight Was 
calculated. Glycosaminoglycans were redissolved in 1 rnI of water, and the 
uronic acid content was determined by the carbazole assay [20). 
Fibronectin Analysis Skins were trimmed to equal surface area, homog-
enized, defatted, and extracted with 5 ml/l00 mg dry weight of 0.05 M Tris 
HCl (PH 7.5), 1.0% sodium dodecyl sulfate (SDS). 0.33 M mercaptoethanol 
and proteolytic inhibitors (1 Ilg/ ml aprotinin, 2 mM phenylmethylsulfonyl 
fluoride, 1 mM N-ethyl maleimide) for 48 h. The suspension was centri-
fuged at 10,000 rpm for 30 min, and the supernatants were electrophoreti-
cally concentrated (Little Blue Tank,lsco Inc. Lincoln, NE) and analyzed for 
fibronectin content by a specific enzyme-linked immunosorbent assay 
(ELISA) utilizing rabbit anti-mouse fibronectin and purified mouse fibro-
nectin (Chemicon. Temecula, CAl [21). 
Collagen Analysis Aliquots of the SDS-soluble and -insoluble fractions 
were hydrolyzed in constant boiling HCl (Pierce Chemical. Rockville, IL) 
for 24 h at 10rC. Amino acid residues were derivatized with 9-Fluorenyl-
methyl chloroformate and resolved and quantified by high-performance 
liquid chromatography as previously described [21). Collagen amounts were 
based on the levels of hydroxyproline, and non-collagenous protein was 
quantified by amino acid analysis. 
VOL. 102, NO.2 FEBRUARY 1994 
A 
c 
RESULTS 
Histochemical Assessments of Glycosaminoglycan Content 
with Mowry's Collidal Iron Stain The blue-staining glycosa-
minoglycans in the upper dermis of normal untreated or vehi-
cle: vehicle-treated hairless mouse skin were very sparse (Fig lA), 
making the steroid-induced decrease less striking than that appear-
ing in human skin [22]. Nevertheless, except for a few small, blue-
staining mast cells, glycosaminoglycans were not detected in the 
steroid-treated skin (Fig lB). The epidermis was equally devoid of 
intercellular glycosaminoglycans. The increase in both dermal and 
epidermal glycosaminoglycans was readily observed in the ster-
oid : tretinoin skin (Fig 1 C). Deep dermal glycosaminoglycans re-
sponded to the different treatments in a similar manner. Steroid 
treatment also greatly reduced the number of cutaneous lipocytes. 
The reduction was prevented by steroid: tretinoin treatment. 
Histochemical Assessment of Mast Cells with Toluidine Blue 
Stain: Quantification by Image Analysis Large dermal mast 
cells are abundant in normal and in vehicle: vehicle-treated hairless 
mouse skin (Fig 2A). These became extremely sparse with ster-
oid : vehicle treatment (Fig 2B) and were even more abundant than 
usual when the steroid was followed by tretinoin (Fig 2C). Quanti-
fication of mast cells showed a significant decrease with steroid 
treatment alone compared to vehicle controls and a return to greater 
than vehicle control val ues with steroid: tretinoin treatment 
(Table I). 
Quantification of Glycosaminoglycans G lycosaminoglycans 
were decreased by the steroid treatment and were increased to 
higher-than-vehicle control levels when the steroid was followed 
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Figure 2. Hairless mouse skin stained with Toluidine blue to visualize mast 
cells (bars, 30 jJ.m) . A) Vehicle: vehicle. Large and numerous mast cells 
(arrollls) are characteristic of normal or vehicle treated hairless mouse skin. 
B) Steroid: vehicle. ~ast cel!s are greatly reduced in number (arrows) and 
often III SIze. C) SterOId: tretmom. Mast cells are large and more numerous 
than in vehicle-treated skin. 
by tretinoin (Tables II, III). This was evident whether quantifica-
tion was by wet or dry weight of tissue, but especially when it was by 
area, which avoids having the relatively low glycosaminoglycan 
content swamped out by increases in total protein synthesis [23]. In 
most cases, there were significantly different changes between the 
three treatment groups. This was especially so with the more reli-
able cetylpyridinium chloride precipitation method (Table II). 
Quantification of Fibronectin by ELISA Steroids have the 
interesting effect of increasing fibronectin synthesis in human fi-
broblasts. We confirmed this steroid effect for mouse skin in vivo 
(Table IV). When the steroid was followed by tretinoin, the ster-
oid-elevated fibronectin content was significantly reduced whether 
measured as ng/mg wet or dry weight, bringing it closer to vehicle 
control values (Table IV). 
Collagen and Noncollagenous Proteins Steroid treatment 
significantly decreased the synthesis of collagen and non-collage-
nous proteins (Table V). Vehicle control levels were maintained by 
Table I. 
Treatment Group' 
Vehicle:vehicle 
Steroid:vehicle 
Steroid:retinoid 
'n=8. 
Quantification of Mast Cells 
Mean Number/Specimen ± SEM' 
774.38 ± 69.77 
528.75 ± 31.60"J 
1246.50 ± 149.51'" 
• Statistical analysis: paircd two-tailed t tcst. 
, Significantly different than vehiclc: p = 0.01 at 95% conlidencc levcl. 
J Significantly differcnt from each other: p < 0.001. 
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Table II. GAG Content by Cetylpyridinium Chloride 
Precipitation (mean ± SEM) 
Wet Weight Dry Weight 
Treatment Group (Jig/mg) (Jig/mg) Jig/cm2 
1. Vehicle:vehiclc 5.10 ± 0.15 24.2 ± 0.8 200 ± 16 
II. Steroid:vehicle 4.89 ± 0.37 20.1 ± 0.7 126 ± 9 
III. Steroid:tretinoin 7.53 ± 0.29 27.4 ± 1.4 247 ± 20 
(n=6) 
Statistical analysis 
Student t test 
I versus II NS P < 0.0025 P < 0.0025 
I versus III p < 0.0005 P < 0.05 P < 0.05 
11 versus 111 p < 0.0005 P < 0.0005 P < 0.0005 
steroid: tretinoin treatment as shown by the lack of a statistical 
difference between the vehicle: vehicle and steroid: tretinoin 
groups. Because of the small difference in collagen synthesis be-
tween the steroid: vehicle and steroid: tretinoin groups, the com-
parison did not prove significant, although a trend was present. The 
greater difference between the two groups with respect to non-col-
lagenous protein synthesis did attain significance (p < 0.01). 
DISCUSSION 
The findings in this study and in our earlier work [1] indicate that 
hairless mouse skin undergoes changes that parallel those in human 
skin chronically treated with corticosteroids. As might be expected, 
the changes occur more rapidly in the thin-skinned mouse, facilitat-
ing systematic study. Epidermal and dermal atrophy occur as in 
humans [22] and are accompanied by decreases in amounts of colla-
gen [14,15], non-collagenous proteins [15], and glycosaminogly-
cans of the dermal matrix [22]. Also as in human skin [22,24], mouse 
mast cells become sparse. 
Comparison with other components of the dermal matrix are 
severely limited by the scarcity of such reports on human skin. For 
example, the effect of corticosteroids on fibronectin has been re-
ported only from it! vitro studies. Although one study, using immu-
nofluorescence, reports inhibition [25], as does the study by Oikar-
inen et al [8], most workers agree that corticosteroids enhance 
fibronectin synthesis [26-30]. Enhancement of fibronectin is in 
agreement with our it! vivo findings, as are most other it! vitro studies 
with regard to corticosteroid effects on the various other dermal 
matrix components [31]. This includes the inhibition of collagen 
synthesis [9-13] and glycosaminoglycans [32- 34]. Elastin is re-
ported to b~ increased it! vitro in the presence of corticosteroids 
l35,36]. This needs confirmation it! vivo and in any case may not be 
applicable to skin. 
A similar scarcity of reports exists with regard to retinoid effects 
on human dermal connective tissue. New subepidermal collagen, 
similar to that found in retinoid-treated photoaged hairless mice 
[37], has been described histologically in humans after long-term 
tretinoin treatment [38]' Additionally, such treatment results in the 
ultrastructural restoration of type VII collagen-anchoring fibrils in 
photodamaged human skin [39] . Increased collagen synthesis has 
Table III. GAG Analysis by Uronic Acid Content (mean ± SEM) 
Wet Weight Dry Weight 
Treatment Group (Jig/mg) (Jig/mg) Jig/cm2 
1. Vehicle:vehicle 0.25 ± 0.01 1.18 ± 0.07 9.68 ± 0.8 
11. Steroid:vehicle 0.25 ± 0.03 1.02 ± 0.08 6.27 ± 0.4 
III. Steroid:tretinoin 0.37 ± 0.02 1.36 ± 0.11 12.21 ± 1.2 
(n = 6) 
Statistical analysis 
Student t test 
I versus II NS NS P < 0.0025 
I versus III p < 0.005 NS NS 
II versus III p < 0.005 P < 0.025 P < 0.0005 
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Table IV. Fibronectin Content (mean ± SEM) 
Wet Weight Dry Weight 
Treatment Group (ng/mg) (ng/mg) ng/cm2 
1. Vehicle:vehicle 1.68 ± 0.10 7.83 ± 0.50 79.0 ± 14.4 
II. Steroid:vehicle 3.55 ± 0.26 14.45 ± 1.03 114.5 ± 10.2 
III. Steroid:tretinoin 2.71 ± 0.35 10.23 ± 1.13 107.7 ± 6.25 
(n = 6) 
Statistical analysis 
Student t test 
1 versus II p < 0.001 P < 0.001 P < 0.05 
1 versus III p < 0.01 P < 0.05 P < 0.05 
II versus III p < 0.05 p < 0.012 NS 
been demonstrated repeatedly in the retinoid-treated photoaged 
hairless mouse [17,40,41]. However, aside from one in vitro study 
reporting enhanced collagen synthesis [42] , retinoid inhibition of 
collagen synthesis in vitro appears to be the rule [43-45]. The few 
studies on glycosaminoglycan levels show agreement between in 
vitro [46,47] and irl vivo results [48], with enhancement by retinoids. 
Retinoids are reported also to increase fibronectin it! vitro [49] and in 
vivo [50].+ 
The interaction of steroids and retinoids was examined in early 
work on the ability of vitamin A to counteract the inhibiting effect 
of corticosteroids on collagen deposition in granuloma models [3_ 
7]. The current study and our previous one [1] are the only recent 
works that test the effects of a retinoid on corticosteroid modulation 
of dermal connective tissue matrix it! vivo. The hairless mouse has 
been used to assess corticosteroid-induced atrophy by other workers 
[2,51], but retinoids were not included in the studies. One study [51] 
was flawed because the opposite flank of treated animals was used as 
control skin. With such thin, highly permeable skin [52] combined 
with transfer o~ applied ~aterial, topical ~reatm~nt very readily 
becomes systemic, producmg atrophy at distant sites (L.H. Klig_ 
man, unpublished results). 
The tretinoin-induced return to nearly normal levels of collagen 
and glycosaminoglycans after diminution of these matrix compo_ 
nents by corticosteroids is understandable in view of the known 
independent action of these drugs. Less obvious is the modulation of 
fibronectin. Retinoids and steroids alone each increase fibronectin 
synthesis. Why therefore, does their sequential application result in 
a lowering of the high levels induced by the steroid? One can specu_ 
late that this reflects the ability of retinoids to normalize abnormal 
processes. For example, retinoids have been reported useful in the 
treatment of hypertrophic and keloid scars [53,54], which suffer 
from excess collagen deposition [55]. It is suggested that this occurs 
by the reduction of collagen synthesis. This contrasts with the reti-
Table V. Effect of Steroid-Retinoid Treatment on Synthesis of 
Collagen and Non-Collagenous Protein 
Treatment Group 
1. Vehicle:vehicle 
II. Steroid:vehicle 
III . Steroid:tretinoin 
(n = 5, mean± 
SEM) 
Statistical anal ysis 
Student t test 
I versus II 
I versus III 
II versus III 
Collagen 
(mg/em2) 
3.12 ± 0.19 
2.60 ± 0.20 
2.82 ± 0.20 
p < 0.05 
NS 
NS 
Non-Collagenous 
Protein 
(mg/em2) 
2.56 ± 0.25 
1.40 ± 0.19 
2.17±0.17 
p < 0.005 
NS 
P < 0.01 
Total Protein 
(mg/em2) 
5.68 ± 0.36 
4.00 ± 0.33 
4.99 ± 0.15 
p < 0.005 
NS 
P < 0.025 
:j: Kligman LH, Cruickshank F, Mezick J, Schwartz E: Quantitative as-
sessment of elastin and fibroneetin in tretinoin treated photoaged hairless 
mouse skin (abstr). J Invest Dermatol 94:543, 1990. 
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noid enhancement of collagen synthesis in photoaged skin, where 
collagen has been degraded [17,40,41]. 
Resolution of such speculations awaits further research with reti-
noids and corticosteroids. The finding in the hairless mouse that 
tretinoin can prevent corticosteroid-induced changes in the connec-
tive tissue matrix, maintaining collagen, glycosarninoglycans, and 
fibronectin at more normal levels, may .be clinically relevant to the 
human situation. The potential for atrophy, whether from topical 
or systemic steroids [56,57], is a serious drawback. If confirmed by 
human testing, the elimination of this major side effect with topical 
tretinoin would serve to increase the benefit/risk ratio of steroid 
therapy. 
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